📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

BRAF inhibitors: resistance and the promise of combination treatments for melanoma. (2017)

First Author: Griffin M

Attributed to: Clinical Translation of Gene Modified T-cell Therapy for Solid Tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.19836

PubMed Identifier: 29100459

Publication URI: http://europepmc.org/abstract/MED/29100459

Type: Journal Article/Review

Volume: 8

Parent Publication: Oncotarget

Issue: 44

ISSN: 1949-2553